Peyronie's disease (PD) is a condition characterized by localized and often
progressive fibrosis and scarring of the penis. This condition has an unkn
own etiology although several hypotheses have been proposed. These include
traumatic, immunologic and genetic causes, We studied the genetics and immu
nology of PD using both molecular biologic and molecular genetic techniques
.
Men (n = 283) with PD were identified by retrospective chart review of one
physician's office practice. These men were contacted by telephone and aske
d to submit to an interview and blood test for genetic studies, Simultaneou
sly, tissue and cells collected in the laboratory were examined by Western
and Northern blot analysis for examination of protein and RNA for expressio
n of HLA.
Of the first 107 men contacted, 24 were available and consented to intervie
w and blood testing. The mean age was 60.3 y with an average duration of PD
of 4.9 y, One patient had a family history of PD while no patients had Dup
uytren's contracture. Twenty patients were considered to have primary disea
se while four were secondary. Eleven patients had tissue prepared for North
ern blot analysis and nine patients were the subject of Western blot analys
is, All tissue, both Peyronie's and control expressed class I MI-IC while n
o tissue expressed class II MHC. The expression of mRNA of class I MHC was
equal for Peyronie's and control patients while the expression at the prote
in level was less in the PD patients.
We conclude that PD may have multiple etiologic agents. One cannot exclude
a class II MHC association but in our population, HLA DQ is not expressed,
Class I MHC may be involved as the expression of class I MHC protein is dif
ferent in Peyronie's patients than in controls. Genetic studies are ongoing
.